Prisma Health-Upstate

prismahealth.org

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

76

Active

10

Phase 3

3

Total enrollment

11,003

Pipeline matrix

Showing 10 of 10 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Intracervical injection of Vasopressin1
Intracervical Injection of saline1
Acetazolamide 500 MG Extended Release Oral1
Methocarbamol1
Standard Opioid1
Standard opioid plus methocarbamol1
antibiotic rinse with suction1
Sweet-cooling1
Sweet non-cooling EC flavor1
Tobacco flavor EC1

Next readouts

  • 2026-05
  • 2026-08-01
  • 2026-08-01
  • 2026-12
  • 2027-06

Top conditions

  • Cancer5
  • Hepatitis C4
  • Ventral Hernia4
  • Substance Use Disorders3
  • Opioid Use Disorder3
  • Anxiety2
  • Obesity2
  • Fetal Anomaly2

Frequently asked questions about Prisma Health-Upstate

How many clinical trials does Prisma Health-Upstate have on ClinicalTrials.gov?
Prisma Health-Upstate is listed as the lead sponsor on 76 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
How many of Prisma Health-Upstate's trials are in Phase 3?
3 of Prisma Health-Upstate's trials are in Phase 3, spread across 10 active drug programs.
What therapeutic areas does Prisma Health-Upstate focus on?
Prisma Health-Upstate's most-studied conditions on ClinicalTrials.gov are Cancer, Hepatitis C, Ventral Hernia, Substance Use Disorders, Opioid Use Disorder.
When are Prisma Health-Upstate's next clinical trial readouts?
Prisma Health-Upstate has 5 upcoming primary-completion readouts tracked here; the soonest is “Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder”, expected around 2026-05.